Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JS9U
|
|||
| Former ID |
DIB003606
|
|||
| Drug Name |
GSK-2231395A
|
|||
| Indication | Streptococcus infection [ICD-11: 1B53; ICD-10: G00.1, G00.2] | Phase 1 | [1] | |
| Company |
GlaxoSmithKline plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00849069) Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.